Table 7 Clinical trials evaluating adoptive cell therapy in patients with TNBC

EGFR/ CD276

NCT05341492

EGFR/B7H3-positive advanced TNBC

I

Recruiting

ROR1-targeted CAR T cell (LYL797)

NCT05274451

ROR1 + relapsed or refractory TNBC

I

Recruiting

NKG2DL-targeting CAR-grafted gamma delta (γδ) T Cells

NCT04107142

Relapsed or refractory solid tumor

I

Unknown

c-Met RNA CAR T cells

NCT01837602

Metastatic breast cancer

0

Completed[170]

CART-TnMUC1 cells

NCT04025216

Advanced TnMUC1⁺ TNBC

I

Recruiting

Anti-meso-CAR vector transduced T cells

NCT02580747

Relapsed or chemotherapy refractory advanced TNBC

I

Recruiting

Mesothelin-specific chimeric antigen receptor-positive T Cells

NCT02792114

Metastatic HER2⁻ breast cancer

I

Active, not recruiting

PD-1⁺ TILS

NCT05451784

Advanced or metastatic TNBC

I/II

Not yet recruiting

TC-510

NCT05451849

Advanced mesothelin-expressing Cancer

I/II

Recruiting